Post-Ischemic Treatment of Recombinant Human Secretory Leukocyte Protease Inhibitor (rhSLPI) Reduced Myocardial Ischemia/Reperfusion Injury

Myocardial ischemia/reperfusion (I/R) injury is a major cause of mortality and morbidity worldwide. Among factors contributing to I/R injury, proteolytic enzymes could also cause cellular injury, expand the injured area and induce inflammation, which then lead to cardiac dysfunction. Therefore, prot...

Descripción completa

Detalles Bibliográficos
Autores principales: Mongkolpathumrat, Podsawee, Kijtawornrat, Anusak, Prompunt, Eakkapote, Panya, Aussara, Chattipakorn, Nipon, Barrère-Lemaire, Stephanie, Kumphune, Sarawut
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8070046/
https://www.ncbi.nlm.nih.gov/pubmed/33924676
http://dx.doi.org/10.3390/biomedicines9040422

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8070046/
https://www.ncbi.nlm.nih.gov/pubmed/33924676
http://dx.doi.org/10.3390/biomedicines9040422

Ejemplares similares